These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2743209)

  • 1. Effect of V-9-M, a peptide fragment derived from procholecystokinin, on memory processes in the rat.
    Takashima A; Itoh S
    Can J Physiol Pharmacol; 1989 Mar; 67(3):228-31. PubMed ID: 2743209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropharmacological properties of V-9-M, a putative neuropeptide derived from procholecystokinin, in the rat.
    Takashima A; Itoh S
    Can J Physiol Pharmacol; 1989 Mar; 67(3):223-7. PubMed ID: 2501013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of cholecystokinin, beta-endorphin, and their antagonists on passive avoidance behavior in rats.
    Itoh S; Katsuura G; Takashima A
    Can J Physiol Pharmacol; 1987 Nov; 65(11):2260-4. PubMed ID: 2966663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effect of cholecystokinin octapeptide on experimental amnesia in rats.
    Katsuura G; Itoh S
    Peptides; 1986; 7(1):105-10. PubMed ID: 3714527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropharmacological profile of V-9-M, a putative neuropeptide derived from procholecystokinin.
    Itoh S; Takashima A
    Prog Neurobiol; 1990; 34(5):429-36. PubMed ID: 2192395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive avoidance deficit following intracerebroventricular administration of cholecystokinin tetrapeptide amide in rats.
    Katsuura G; Itoh S
    Peptides; 1986; 7(5):809-14. PubMed ID: 3797342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory effect of caerulein and its analogs in active and passive avoidance responses in the rat.
    Itoh S; Takashima A; Igano K; Inouye K
    Peptides; 1989; 10(4):843-8. PubMed ID: 2531375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
    Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of beta-(Tyr9)melanotropin-(9-18) on active avoidance behavior, electroconvulsive shock-induced amnesia and T-discrimination learning of rats.
    Telegdy G; Vécsei L; Bollók I; Schally AV
    Peptides; 1986; 7(1):11-3. PubMed ID: 3714528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterostatin (APGPR) enhances memory consolidation in mice.
    Ohinata K; Sonoda S; Shimano T; Yoshikawa M
    Peptides; 2007 Mar; 28(3):719-21. PubMed ID: 17175068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide.
    Kádár T; Fekete M; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(4):269-74. PubMed ID: 6291322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide (VIP) causes memory impairment in passive avoidance responding of the rat.
    Takashima A; Maeda Y; Itoh S
    Peptides; 1993; 14(5):1067-71. PubMed ID: 8284258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures.
    Kovács GL; Veldhuis HD; Versteeg DH; De Wied D
    Brain Res; 1986 Apr; 371(1):17-24. PubMed ID: 3708341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of piracetam and of standardized ginseng extract on the electroconvulsive shock-induced memory disturbances in "step-down" passive avoidance.
    Lasarova MB; Mosharrof AH; Petkov VD; Markovska VL; Petkov VV
    Acta Physiol Pharmacol Bulg; 1987; 13(2):11-7. PubMed ID: 3673597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to the anti-avoidance properties of cholecystokinin-octapeptide.
    Cohen SL; Knight M; Tamminga CA; Chase TN
    Peptides; 1983; 4(1):67-70. PubMed ID: 6306617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a spirocyclic cyclodipeptide derivate of MIF on passive avoidance behavior and amnesia in rats.
    Krejcí I; Dlabac A; Vanzura J; Kosnar J
    Act Nerv Super (Praha); 1986 Dec; 28(4):241-6. PubMed ID: 2881422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of brain natriuretic peptide-32 on electroconvulsive shock-induced amenesia in rats. The role of neurotransmitters.
    Bidzseranova A; Varga J; Telegdy G
    Eur J Pharmacol; 1993 Mar; 232(2-3):305-8. PubMed ID: 8096818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cholecystokinin-related peptides on retention of passive avoidance behaviour.
    Fekete M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1982; 60(4):237-42. PubMed ID: 6314742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Learning and memory processes of an ACTH4-9 analog (ebiratide; Hoe 427) in mice and rats.
    Hock FJ; Gerhards HJ; Wiemer G; Usinger P; Geiger R
    Peptides; 1988; 9(3):575-81. PubMed ID: 2843833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade.
    Mazzola C; Micale V; Drago F
    Eur J Pharmacol; 2003 Sep; 477(3):219-25. PubMed ID: 14522360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.